Janus Henderson Group PLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1,820.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,388,641 shares of the healthcare conglomerate’s stock after acquiring an additional 2,264,242 shares during the quarter. Janus Henderson Group PLC owned about 0.25% of UnitedHealth Group worth $442,896,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of UNH. 1st Global Advisors Inc. boosted its position in shares of UnitedHealth Group by 32.1% during the 1st quarter. 1st Global Advisors Inc. now owns 23,163 shares of the healthcare conglomerate’s stock valued at $3,799,000 after acquiring an additional 5,624 shares during the last quarter. Beacon Trust Co. raised its holdings in shares of UnitedHealth Group by 5.6% during the 1st quarter. Beacon Trust Co. now owns 43,322 shares of the healthcare conglomerate’s stock valued at $7,164,000 after buying an additional 2,300 shares in the last quarter. Savant Capital LLC raised its holdings in shares of UnitedHealth Group by 6.3% during the 1st quarter. Savant Capital LLC now owns 4,974 shares of the healthcare conglomerate’s stock valued at $816,000 after buying an additional 294 shares in the last quarter. Raymond James Financial Services Advisors Inc. raised its holdings in shares of UnitedHealth Group by 10.8% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 344,616 shares of the healthcare conglomerate’s stock valued at $56,534,000 after buying an additional 33,656 shares in the last quarter. Finally, Northstar Wealth Partners LLC purchased a new position in shares of UnitedHealth Group during the 1st quarter valued at about $238,000. Hedge funds and other institutional investors own 86.20% of the company’s stock.
Shares of UnitedHealth Group Incorporated (UNH) traded up $3.76 during trading on Monday, reaching $223.91. The company’s stock had a trading volume of 2,233,200 shares, compared to its average volume of 3,110,479. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The stock has a market cap of $215,500.00, a PE ratio of 23.32, a P/E/G ratio of 1.66 and a beta of 0.66. UnitedHealth Group Incorporated has a 1-year low of $156.09 and a 1-year high of $231.77.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be paid a $0.75 dividend. The ex-dividend date is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.34%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.09%.
In other news, insider Larry C. Renfro sold 50,574 shares of the business’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now directly owns 195,625 shares of the company’s stock, valued at $38,755,268.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares in the company, valued at $13,652,503.47. The disclosure for this sale can be found here. Insiders sold a total of 62,606 shares of company stock worth $12,677,525 over the last ninety days. Insiders own 0.89% of the company’s stock.
UNH has been the topic of a number of research reports. ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Cantor Fitzgerald raised their price objective on UnitedHealth Group to $225.00 and gave the company an “overweight” rating in a report on Wednesday, October 18th. Credit Suisse Group initiated coverage on UnitedHealth Group in a report on Thursday, November 2nd. They set an “outperform” rating and a $233.00 price objective on the stock. UBS reissued an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, August 24th. Finally, Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. Three equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $224.56.
COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Incorporated (UNH) Shares Bought by Janus Henderson Group PLC” was originally reported by Week Herald and is the property of of Week Herald. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://weekherald.com/2017/12/11/unitedhealth-group-incorporated-unh-shares-bought-by-janus-henderson-group-plc.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.